Ensysce Biosciences, Inc. (Ensysce) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses. 

Biotechnology

Ensysce Biosciences

D. Lynn Kirkpatrick

Steve Martin

Jeffrey Millard

William Schmidt

Linda Pestano

Geoff Birkett

Dave Humphrey

The Scientific Advisory Team at Ensysce Biosciences provides expert guidance on the development of the company's innovative, abuse-deterrent prescription drugs. Comprised of multiple Scientific Advisors, this team evaluates emerging research, ensures the scientific rigor of clinical trials, and advises on regulatory strategies to advance safer pharmaceutical solutions.


Scientific Advisory Team

Leadership Team

��

Scientific Advisory Team

About

Team members

Other teams at Ensysce Biosciences

Leadership Team

��������

Scientific Advisory Team

About

Team members

Other teams at Ensysce Biosciences

Leadership Team

��